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Abstract
One of the main problems of drug design is that of optimizing the drug–target interaction. In the
case in which the target is a viral protein displaying a high mutation rate, a second problem arises,
namely the eventual development of resistance. We wish to suggest a scheme for the design of
non–conventional drugs which do not face any of these problems and apply it to the case of HIV–1
protease. It is based on the knowledge that the folding of single–domain proteins, like e.g. each
of the monomers forming the HIV–1–PR homodimer, is controlled by local elementary structures
(LES), stabilized by local contacts among hydrophobic, strongly interacting and highly conserved
amino acids which play a central role in the folding process. Because LES have evolved over myriads
of generations to recognize and strongly interact with each other so as to make the protein fold fast
as well as to avoid aggregation with other proteins, highly specific (and thus little toxic) as well
as effective folding–inhibitor drugs suggest themselves: short peptides (or eventually their mimetic
molecules), displaying the same amino acid sequence of that of LES (p–LES). Aside from being
specific and efficient, these inhibitors are expected not to induce resistance: in fact, mutations
which successfully avoid their action imply the destabilization of one or more LES and thus should
lead to protein denaturation. Making use of Monte Carlo simulations within the framework of a
simple although not oversimplified model, which is able to reproduce the main thermodynamic as
well as dynamic properties of monoglobular proteins, we first identify the LES of the HIV–1–PR
and then show that the corresponding p–LES peptides act as effective inhibitors of the folding of
the protease which do not create resistance.
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I. INTRODUCTION
Because human immunodeficiency virus type–1 Protease (HIV–1–PR) is an essential en-
zyme in the viral life cycle, its inhibition can control acquired immune deficiency syndrome
(AIDS).
The main properties inhibitory drugs must display are efficiency and specificity. Con-
ventionally, this is achieved by either capping the active site of the enzyme (competitive
inhibition) or, binding to some other part of the enzyme, by provoking structural changes
which make the enzyme unfit to bind the substrate (allosteric inhibition). All the inhibitors
of the HIV–1–PR available in the market (Indinavir, Sanquinavir, etc.) and which have been
approved by FDA follow the former paradigm.
The large production of virions in the cell, coupled with the error prone replication mech-
anism of retroviruses, lead to escape mutants, drug resistance, and eventually persistance of
the disease. Under the selective pressure of drugs, HIV–1–PR either mutates at the active
site or at sites controlling its conformation, in such a way that the enzymatic activity is
essentially retained, while the drug is not able to bind to its target anymore. The first signs
of the failure of the drug usually takes place 6–8 months after the starting of the treatment
[1].
We wish to suggest a novel type of HIV–1–PR inhibitor which interfere with the folding
mechanism of the protein, destabilizing it and making it prone to proteolysis. These drugs
are expected to be, aside from highly specific, perdurably efficient. In fact, as we shall see
in the following, drug induced mutations will necessary affect sites important for the folding
and for the stability of the protease, and consequently lead to its denaturation.
HIV–1–PR is a homodimer (cf. Fig. 1), that is a protein whose native conformation
is built out of two (identical) disjoint chains. Sedimentation equilibrium experiments have
shown that, in a neutral solution (pH=7, T = 40C), the protease folds according to a
three–state mechanism (2U → 2N → N2), populating consistently the monomeric native
conformation N [2]. This result (cf. also the Appendix A) is supported by NMR studies
of mutants where the interaction across the interface is weakened but the monomer retain
its native conformation [3], by all–atom simulations of the HIV–PR monomer in explicit
solvent [4] and by Go¯–model simulations of the dimer [5]. The dimer dissociation constant
(2N ↔ N2) is found to be kd = 5.8µM at T = 4
0C [2]: for instance, in a 30 µM solution 44%
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of proteins are in monomeric form. This allows one to conclude that, at neutral pH, each
monomer of the protein folds following the same hierarchical folding mechanism of single
domain, monomeric proteins [6]: after the monomer has reached the native state, it diffuses
to find another folded monomer to associate with.
A number of experimental and theoretical evidences suggests that globular, single–domain
proteins avoid a time–consuming search in conformational space, folding through a hierar-
chical mechanism. Ptitsyn and Rashin observed a hierarchical pathway in the folding of
Mb [7]. Lesk and Rose identified the units building the folding hierarchy of Mb and RNase
on the basis of geometric arguments [8], deriving the complete tree of events which lead
these proteins to the native state. All these studies describe a framework where small units
composed of few consecutive amino acids build larger units which, in turn, build even larger
ones, which eventually involve the whole protein [9]. The kinetic advantage of this mecha-
nism is that, at each level of the hierarchy, only a limited search is needed for the smaller
units to coalesce into the larger units belonging to the following level [10].
Lattice model calculations [11, 12] have shown that the folding of a small monomeric
protein proceeds, starting from an unfolded conformation, follow a hierarchical succession of
events: 1) formation of local elementary structures (LES, containing 20%–30% of the proteins
amino acids) stabilized by few highly conserved, strongly–interacting (”hot”) hydrophobic
amino acids (≤ 10% of the proteins amino acids) lying close along the polypeptide chain,
2) docking of the LES into the (postcritical) folding nucleus [13], that is formation of the
minimum set of native contacts which brings the system over the major free energy barrier of
the whole folding process, 3) relaxation of the remaining amino acids on the native structure
shortly after the formation of the folding nucleus. The ”hot” sites, which stabilize the LES
are found to be very sensitive to (non–conservative) point mutations. Since most of the
protein stabilization energy is concentrated in these sites, mutating one or two of them has
a high probability of denaturing the native state. On the other hand, mutating any other
site (”cold” sites, even those ”cold” sites belonging to the LES) has in general little effect
on the stability of the protein [14, 15].
Making use of the same model it has been shown that it is possible to destabilize the
native conformation of a protein making use of peptides whose sequence is identical to that
of the protein LES [16]. Such peptides interact with the protein (in particular with their
complementary fragments in the folding nucleus) with the same energy which stabilizes the
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nucleus, thus competing with its formation.
There are two important advantages of these folding–inhibitors with respect to conven-
tional ones. First, their molecular structure is suggested directly by the target protein.
One has not to design or to optimize anything, just find which are the LES of the protein
that has to be inhibited. The design has been performed by evolution through a myriad
of generations of the virus (or of the organism which expresses the protein). Moreover, it
is unlikely that the protein can develop resistance through mutations. In fact, the present
inhibitor binds to a LES, and a protein cannot mutate a LES [14], in any case not those
”hot” amino acids which are essential to stabilize it as well as to bind to the other LES to
form the folding nucleus [15], under risk of denaturation. Note that, within this context,
neutral mutations (e.g., hydrophobic–hydrophobic) of these hot amino acids are possible, as
they do not essentially change the stability of the corresponding LES, nor the strenght and
specificity with which LES dock to form the folding nucleus.
II. MODEL CALCULATIONS OF THE FOLDING PROPERTIES OF HIV–1 PR
The investigation of the folding of the HIV–1 PR has two goals: i) to validate the model
which will be employed to study the effect of the inhibitor peptides and ii) to help locate the
local elementary structures of the protein. For this purpose, use is made of a modified Go¯
model. In standard Go¯ model calculations [17], as that carried out by Levy and coworkers [5]
in their study of the HIV–1–PR, the interaction between each pair of amino acids is described
by a square well whose bottom lies at the same energy for all native pairs and at zero or
positive energy for non–native pairs. Such a treatment insures the native conformation
to be the global energy minimum of the system, providing at the same time a realistic
description of the entropic features of the chain. It however fails in providing any chemical
characterization of the amino acids, treating all of them on equal footing. To account for the
diversity existing between amino acids, we assign to each native pair an interaction energy
obtained averaging Gromacs [18] force field around the native conformation of the monomer.
This procedure has proven useful to account for the folding properties of a number of small,
single–domain proteins [19].
The model pictures each amino acid as a spherical bead, making inextensible links with
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the following one. The amino acids interact through a contact potential of the kind
U({ri}) =
∑
i+2<j
[
Bijθ(R − |ri − rj|)θ(R− |r
N
i − r
N
j |) + ǫHCθ(0.99 · |r
N
i − r
N
j | − |ri − rj |)×
× θ(R − |rNi − r
N
j |) + ǫHCθ(R− |ri − rj |)[1− θ(R − |r
N
i − r
N
j |)]
]
(1)
where ri is the coordinate of the Cα atom of the ith amino acid, r
N
i is the coordinate in the
crystallographic native conformation (pdb code 1BVG), θ(x) is a Heaviside step function,
Bij is the interaction energy between ith and jth amino acid, R the interaction range (which
in the following calculations is set equal to 7.5A˚) and ǫHC is the hard core repulsion, set
to 100 kT . Accordingly, the first term of the potential function describes the attraction
between native pairs, the second term the hard core between native pairs, its range being
equal to the 99% of the native distance, and the last term describes the repulsion between
non–native pairs. Moreover, we assume that residue i interacts with residue i + 2 only
through a hard core repulsion of range R/2.
To determine the quantity Bij all atom molecular dynamic simulations were carried out
making use of the Gromacs package, treating explicitely the solvent. The simulations were
done for 1 ns at room temperature around the native conformation of the dimer. During
this time interval the overall RMSD of the system did not exceeded 2.5A˚. The values Bij
are the result of the average over the full simulation of the interaction energies between the
different pairs of amino acids.
The simulations carried out making use of the modified Go¯ model were performed in a
100A˚ box with periodic boundary conditions (equivalent to a 10 mM concentration), and
temperatures ranging from 1 to 5 kJ/mol (in the following, temperatures will be expressed
in kJ/mol, setting Boltzmann’s constant equal to 1: for instance, 300K correspond to ≈2.5
kJ/mol). From these simulations,characterization of the dimer thermodynamical quantities
have been obtained by means of a modified multi–histogram techniques [20]. The resulting
dimer specific heat (per monomer) is displayed in Fig. 2(a) (solid curve). Consistent with
the findings of ref. [5], it displays two peaks, one at T1 = 2.8 kJ/mol and one at T2 = 4.1
kJ/mol.
To better quantify the properties of the protein we introduce the parameter qE defined
as the fraction of the native energy (e.g., qE = 1 means that the dimer is in the native
conformation). We will use the parameter qE also with respect to the monomer or to the
interface, to indicate the fraction of energy within the monomer or at the interface of a given
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conformation. In Fig. 2(b) is displayed the value of the parameter qE associated with the
interaction within each of the monomers forming the HIV–1–PR (black dashed curve),as
well as that associated with the dimerization, that is the interaction between the monomers
(dashed gray curve). The decrease in the interaction energy at the interface between the
two monomers taking place at T1 indicates that the associated peak in the specific heat of
the two chains (continuous curve in Fig. 2(a)) marks the transition between the dimeric
and the monomeric forms of the protein. Just above T1, each monomer is still in the native
basin of attraction, displaying a qE ≈ 0.75. The temperature T2 corresponds to the (weak)
transition to unfolded monomers (qE < 0.5, cf. dashed black curve in Fig. 2(b)).
The same kind of weak transition is found for simulations of an HIV–1–PR monomer alone
(dashed curve in Fig. 2(a)), although at a slightly lower temperature (Tmonf = 3.8 kJ/mol).
The weakness of the (monomer) folding transition (taking place at T2) is associated with a
faint degree of cooperativity, as testified by the low value assumed by the two–state param-
eter [21] κ2 = 0.18. This parameters ranges from 1 for fully cooperative transitions, to 0 for
non–cooperative transitions. Although it is well known that simplified models understimate
the cooperativity of the folding transition [22], the HIV–1–PR monomer displays a value of
κ2 which is much lower than that of other proteins simulated with the same model (e.g.,
src–SH3 displays κ2 = 0.38, even if it is shorter than the HIV–1–PR).
The physical reason why the folding of the HIV–1–PR monomer is much less cooperative
than other monoglobular proteins can be found on the properties of the folding nucleus of
each of the monomers forming this protein. As discussed below, the folding nucleus of the
protease is built out of the LES containing the monomers 24–34, 83–93 and 75–78. Due to
the distance between the two LES along the chain, the assembly of the folding nucleus leaves
a conformational freedom to the rest of the chain (specifically, to the fragment 35–75 at least
and likely also to the fragment 35–83) uncommon among other proteins. This is testified by
the large equilibrium RMSD found under folding conditions (up to 10A˚ for T < 3.8 kJ/mol)
in simulations of the monomer alone (dashed curve in Fig. 2(c)), where the folding nucleus
is essentially formed (dashed–dotted black curve in Fig. 2(b)). Within this context, we note
that the basin of attraction of the monomeric native state extends to conformations with
RMSD of 10A˚, correspondindg to a typical qE of 0.7 (cf. Fig. 7(a)), while the unfolded
states has a RMSD of the order of 12A˚ and beyond. The large fluctuations of the fragment
35–75 (or 35–83) when the nucleus is formed produce a shoulder in the specifc heat at low
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temperatures (cf. dashed curve in Fig. 2(a)) and blurr the folding transition at Tmonf .
With the same model it is possible to run dynamical simulations, starting from random
conformations and follow the folding of the protein into the native state. Since we are
interested in inhibiting the folding of the HIV–1–PR monomer, we will concentrate on the
dynamics of the monomer. The overall dynamics can be followed through the plot of [qE ](t),
that is the fractional native energy as a function of time, averaged over 100 independent
runs. The result at T = 2.5 kJ/mol is displayed as a solid curve in Fig. 3, indicating
an exponential process of characteristic time τ = 2.9 · 10−7s (cf. Appendix B), consistent
with the two–state picture. The model provide also information concerning the formation
of each contact, through the probability pij(t) that the contact between residues i and j is
formed at time t. A number of contacts are stabilized early (sub–nanosecond time scale)
following an exponential dynamics. This is the case of, for example, contact 87–90. Contacts
between residues which are far along the chain are formed later, following a non–exponential
dynamics, which indicate that their formation is dependent on some other event[19]. The
earliest among them involve the fragments 22–34 and 77–93 after an average time τ ≈ 10−7
s. As an example, in Fig. 3 is displayed the formation probability of the contact 31–89.
In Fig. 4 is summarized the hierarchy of formation of native contacts of HIV–1–PR, the
different gray levels corresponding to different time scales, while in Table I are listed the
parameters associated with selected contacts. The picture that emerges is that local contacts
within fragments 83–93 and in the beta–hairpin 42–58 form first. Note also the very fast
formation of contact 25–28 belonging to the fragment 22–34. Then the beta–turns 14–19
and 64–72, again built out of local residues. The next event is the assembly of the nucleus
involving fragments 22–34 and 83–93, which is further stabilized by the contribution of the
strongly–interacting segment 75–78. Finally, the rest of the residues come to place.
Summing up, the model suggests that LES are built of residues which lie in the regions 83–
93, 24–34 and likely also 75–78. This result essentially agrees with the indications provided
by the studies of Levy and coworkers [5]. These authors have found that the group of amino
acids 27–35 and 79–87 are essential in the folding of the protein.
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III. LOCALIZATION OF THE LES: INDIRECT METHODS
The direct inspection of the dynamics of the HIV–1 PR obtained by means of model
simulations of the folding have suggested which are the LES controlling the folding of the
monomer. It can be interesting to study other techniques to localize the LES, in order both
to substantiate the findings of the model, and to develop a more economical method to be
used in the case of other proteins one wishes to inhibit.
A. Evolutionary data
Since LES are responsible for guiding a protein to its native conformation, it is likely that
evolution pays particular care in conserving their sequence. In fact, model simulations have
shown that residues building the LES can only undergo conservative point mutations (e.g.,
hydrophobic–hydrophobic), at the risk of denaturing the protein [15]. Consequently, LES
are highly conserved in families of structurally similar proteins [23]. Comparative studies of
a number of protein families have shown that this is indeed the case [24].
A measure of the degree of conservation of residues in a family of proteins is provided by
the entropy per site S(i) ≡ −
∑
σ pi(σ) log pi(σ), where pi(σ) is the frequency of appearence of
residue of type σ at site i in the proteins belonging to the family. In order to be statistically
meaningful, we have plotted in Fig. 5 (with a solid line), the entropy calculated over a
family of 28 uncorrelated proteins (i.e., sequence similarity lower than 25%), structurally
similar to HIV–1–PR [25]. As seen from the figure, the most conserved regions are those
involving residues 22–33 and 81–90. Even disregarding the statistical caution and calculating
the entropy over 462 proteins [26] displaying any sequence similarity to HIV–1–PR (dashed
line in Fig. 5) the plot indicates the same regions as the most conserved. Note that the
conservation of residues 25–27 is anyway not unexpected, in that they build the active site
of the protease (D25, T26 and G27).
Another important source of information concerning the HIV–1–PR is provided by the
study of its sequences in specimens coming from infected individuals. Being a retrovirus, HIV
can replicate very fast but very imprecisely, thus displaying a rather fast evolution rate. This
evolution is reflected by the appearence of a manyfold of mutated HIV–1–PR which retain
their folding features. In Table II are listed the mutations observed in 28417 isolates coming
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from patients infected with HIV–1–PR [27]. Since some mutations can be conservative, that
is substitute an amino acid with another displaying similar chemical properties, we also
display on the table the lowest PAM250 [28] score associated with the mutations in each
site. A positive PAM250 score indicates a conservative mutation. Although the fragments
with no mutations or with only conservative mutations are too many to let one identify the
LES from this information alone (probably because of the limited statistics in the database),
the fact that only conservative mutations fall in the fragments 24–34, 83–93 and 75–78 is
consistent with the description of the folding nucleus made above.
B. Static energy features
In order to become stable at an early stage of the folding process, LES must carry a
significant fraction of the total energy of the protein in its native conformation. We have
analyzed the native interaction Bij between the amino acids following the scheme described
in ref. [29], through an eigenvalue decomposition of the matrix. The lowest energy state
(λ1=-121.2 kJ/mol) displays a large energy gap (i.e. -12.9 kJ/mol≈ 5kT ) with respect to
the next eigenvalue, indicating a core of strongly interacting amino acids. We display in Fig.
6 the eigenvector associated with the lowest energy eigenvalue, which highlights to which
extent the different amino acids participate to this core. The largest amplitudes involve
residues 25–34, 57–65, 75–77 and 83–90. These regions of residues overlap well with the
conserved regions mentioned above in connection with Fig. 5.
Another way of representing the interaction matrix ‖ Bij ‖ is to consider the interaction
between fragments S1 = (13 − 21), S2 = (24 − 34), S3 = (38 − 48), S4 = (50 − 55),
S5 = (56 − 66), S6 = (67 − 72), S7 = (75 − 78), S8 = (83 − 93). The corresponding 8 × 8
energy map is essentially codiagonal, the associated energy of the interacting chain segments
being −1936 kJ/mol as compared to the MD simulation native energy −2722 kJ/mol. In
other words, the S1 − S8 representation of the folded monomer accounts for ≈ 70% of the
calculated native conformation energy. Because this representation contains 70 residues,
it would be tempting to conclude that the native energy is uniformly distributed over all
the amino acids. Within this context, it is useful to calculate the difference between the
native S1–S8 energy map and that associated with the unfolded (U) state (q < 0.3). For
this purpose, Go¯ model simulations (cf. Sect. II as well as discussion below) have been
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carried out to obtain a statistically representative ensemble of U–states, from which we have
extracted an average set {qi}U of similarity parameters. Weighteing each contribution to
the elements of the 8× 8 matrix by the corresponding difference (qN − qU)i, one obtains the
energy map shown in Table III. It is seen that the S1− S8 representation divides into three
blocks: a) one composed of segments S2, S7 and S8, b) one composed of segments S1 and
S6, and c) one containing segments S3, S4 and S5. While the average energy per residue in
those block is −5.3 kJ/mol, that associated with S2+S7+S8 and S1+S6+S3+S4+S5 is -8.3
kJ/mol and -4.9 kJ/mol, respectively.
The above results indicate that the S2, S7 and S8 segments qualify as LES (folding units)
of each of the two monomers of the HIV-1-PR dimer, LES which form in their native confor-
mation the (post critical) folding nucleus (FN). It is interesting to note that drug induced
mutations in the amino acids belonging to these LES (L24I, D30N, L33F, V77I, I84V, I85V,
N88D and L90M [1]), lead to a folding nucleus energy equal to -1500 kJ/mol, as compared
to -796 kJ/mol for the wild type sequence FN, that is to an increase of almost a factor of 2
in the stability of the system, considering the effect of all mutations simultaneously. In fact,
single selected mutations add to the FN stability 5-10 kJ/mol. Within this context and that
of Fig. 6 one can identify sites 33, 75, 76, 84 and 89 as ”hot” sites.
C. Further evidence
Wallqvist and coworkers [30] investigated the HIV–1–Protease molecule for the occurence
of cooperative folding units that exhibit a relatively stronger protection against unfolding
than other parts of the molecule. Unfolding penalities are calculated forming all possible
combinations of interactions between segments of the native conformation and making use
of a knowledge–based potential. This procedure identifies a folding core in HIV–1–PR
comprising residues 22–32, 74–78 and 84–91, residues that form a spatially close unit of a
helix (84–91) with sheet (74–78) above another β–strand ((22–25), containing the active site
residues D25, T26 and G27) perpendicular to these elements.
Making use of a Gaussian network model, Bahar and coworkers [31] studied the normal
modes about the native conformation of HIV–1–Pr. ”Hot” residues, playing a key role in
the stability of the protein, are defined as those displaying the fastest modes. In this way
are identified regions 22–32, 74–78 and 84–91 as folding core of the protein. These regions
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match with those displaying low experimental Debye-Weller factors, that is low fluctuations
in the crystallographic structure.
Calculation of ϕ–values by means of Go¯–model simulations performed by Levy and
coworkers [5] have located a major transition state where only regions 27–35 and 79–87
are structured. The protein then reaches the native state, overcoming another minor tran-
sition state, and subsequently dimerizes into the biologically active structure.
Cecconi and coworkers [32] have calculated the stability temperatures associated with
each contact of the protease, again making use of a Go¯ model. They find that key sites to the
stability of partially folded states, that is those displaying the lowest stability temperatures,
are 22, 29, 32, 76, 84 and 86.
IV. INHIBITION OF HIV–1 PR
The central issue of the present work is to show that it is possible to destabilize the native
state of the HIV–1 PR monomer, shifting the equilibrium to the unfolded state, by means of
short peptides displaying the same sequence as one of the LES (which we shall call peptides
p–LES).
As emerged from the calculations discussed in Sect. II and the evidence presented in Sect.
III, the segments 24–34 (S2), 83–93 (S8) and likely 75–78 (S7) qualify as LES of the HIV–
1–PR monomer, and thus as leads of inhibitors of the enzyme, with the following provisos.
Segment S7 is a so called open LES (cf. ref. [33]), too short to be specific. Concerning
the S2 LES, it contains the active site (residues 25, 26 and 27). In the model studies of
the design of good folders, neither we nor any other group has ever considered the role
the conserved amino acid belonging to the active site play in the resulting sequence, nor
in the folding properties of the protein. Nonetheless one knows that this role is likely to
be important. In particular, while considerations of hydrophobicity and/or capability to
establish the largest number of native contacts suggests that the most strongly interacting
amino acids providing the stabilization of the LES and thus of the folding nucleus should be,
in the native conformation, well protected and buried inside the protein, those associated
with the active site should be reachable by the substrate and thus lay on the surface of the
enzyme. The corresponding frustration is well exemplified by the anticorrelation observed
between the entropy values associated with sites 26 and 27 (low) and the corresponding
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eigenvector components (also low) shown in Figs. 6 and 5. This anticorrelation becomes
even stronger if one compares it with the perfect correlation existing between the values
of the entropy (low) and of eigenvector (high) associated with sites 33 and 85 essential in
the folding process (hot sites) but not connected with the active site. Summing up, we do
not know what the consequences are of this frustration in the design of nonconventional
inhibitors. Consequently, in what follows we shall exclusively concentrate on the LES S8,
and on the inhibitory properties the peptide p–S8 has.
For this purpose, we have performed equilibrium simulations of the system composed of
the HIV–1 PR monomer and a number of p–LES (p–S8) corresponding to the fragment 83–
93 of the protein (S8). The joint probability distribution p(qE , RMSD) of the native relative
energy fraction qE and of the RMSD (normalized, i.e., divided by the number of residues)
for the case of 3 p–LES at T = 2.5 kJ/mol is displayed in Fig. 7(b), to be compared with
that of the monomer alone (Fig. 7(a)). Consistently with the folding transition observed in
Fig. 2 and with the discussion of Sect. II, we define as native state the region of Fig. 7(a)
characterized by qE > 0.7 and RMSD< 10A˚ (this region is delimited with a dashed curve
in the figure). The effect of the p–S8 is to decrease drastically the population of the native
state and increase at the same time that of the unfolded state.
The increase of the peak associated with the unfolded state is caused by the appearence
of conformations where the p–S8 peptides are bound to the fragment 24–34 (S2) of the
protein, preventing the actual LES 24–34 to find its native conformation. An example of
such conformation is shown in Fig. 8, corresponding to the values qE = 0.6 and RMSD=11A˚.
This conformation is particularly stable because the interaction between the p–LES and the
monomer is of the order of −165 kJ/mol, the same amount of energy which stabilizes the
nucleus of the protein. Note also that more than one p–S8 is able to bind at the same time
to the monomer, increasing the degree of denaturation.
In Fig. 9 is displayed the equilibrium population pN of the native state as a function
of the number np of p–S8 peptides. The inhibitory effect of the peptides is already present
at np = 1 (i.e., a concentration of p–S8 equal to the concentration of protein, in terms of
number of chains), in which case the stability of the native state is reduced by ≈ 30% with
respect to the situation with no peptides, while for nP = 4 the value of pN becomes ≈ 0.25.
We have repeated the same calculation with control peptides whose sequences are equal to
that of the fragments 5–15 and 61–70 of the monomer. In all cases a slight decrease of the
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stability has been observed. However, the control peptides are not able to disrupt to any
extent the folding nucleus and thus to prevent the monomer to reach the native state.
We have also calculated how inhibition depends on temperature, carrying out simulations
of folding of the monomer protein in presence of three p–S8 at two temperatures different
from that used in connection with the results displayed in Fig. 9. At T = 3.5 kJ/mol the
value of pN drops to 0.01, while at the (very) low temperature T = 2 kJ/mol the simulation
leads to pN = 0.98, indicating that p–S8 becomes ineffective. Within this context, the
following considerations are in place. At the ”biological” temperature T = 2.5 kJ/mol our
simulations are well equilibrated, in the sense that the system has gone in and out the
native conformation a large number of times and the system has lost memory of the initial
condition (e.g., simulations starting from the native conformation give the same results as
simulations starting from a random, unfolded conformation). At T = 2 kJ/mol this is not
true anymore. In fact, since in this case the dynamics is much slower, it is not feasable to
perform simulations for long enough time so that the system becomes equilibrated.
In any case, the low–temperature simulations performed give a strong signal about a
diminished inhibitory effect of the p–S8. This is not unexpected, due to the fact that the
preference the protein has to bind a p–LES instead of its own LES is mainly entropical.
More precisely, the protein can either make its S2– and S8–LES interact to build the folding
nucleus (in which case the protein folds) or make its S2–LES interact with the p–S8 peptide
(in which case the protein does not fold). The difference between the two situations can
thus be understood as follows. In the case where two LES bind to each other in the native
conformation the whole system gains (potential energy) from the folding of the rest of the
protein, paying at the same time the entropic cost associated with this phenomenon. In the
case in which a LES binds a p–LES, the system essentially gains the same (potential) energy
as in the previous case, due to the fact that most of the stabilization energy is concentrated in
the interaction among the LES. On the other hand, the entropy cost is only that associated
with the freezing out the degrees of freedom of the peptide. This entropic cost decreases
with the number np of p–LES in the system as TS
rot−transl−T log np, the roto–translational
entropy of the p–LES depending weakly on np at low concentrations, as in the case under
discussion. Consequently, regardless the stabilization energy of the protein monomer, there
always exists a number np of p–LES such that the free energy of the unfolded state is lower
than that of the native state. At the ”biological” temperature T = 2.5 kJ/mol we observe
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(cf. Fig. 9) that np = 1 is enough to destabilze the native state to a measurable extent.
When the temperature is lowered, entropy plays a less important role (i.e., F = E − TS)
and the equilibrium state becomes the lowest potential energy state, that is the native state.
The fact that the p–S8 destabilizes the monomeric protease is a sufficient condition to
prevent the replication of the virus. This in keeping with the fact that the monomer is
at equilibrium with the dimer. Consequently, the destabilization of the monomer shifts the
equilibrium of the system towards the unfolded state. Moreover, the fact that the monomeric
state is consistently populated under physiological conditions suggests that this shift would
be fast and effective.
Nonetheless, it is interesting to follow the interaction between the p–LES and the HIV–1–
PR, starting from the protein in its dimeric native conformation. For this purpose, we have
performed 1010 MCS simulations of a system composed of the dimer and three p–S2 peptides
at T = 2.5 kJ/mol. Due to its large size, the equilibration of the system is computationally
quite demanding (3 weeks on a Xeon workstation). The population pN of the native dimeric
state (using the same definition as above) is 0.05, to be compared with 0.304 for the case
in which the isolated dimer is evolved starting again from the native conformation. The
detailed values for the populations of the various states are given in Table IV. The large
errors ascribed to these numbers reflect the computational difficulties in equilibrating the
system.
A snapshot of the result of the three p–S8 plus dimer simulation is shown in Fig. 10. It
is seen that the p–S8 peptides are able to bind to the protein, blocking the way of the native
S8 LES to dock the S2 LES, thus disrupting the folding nucleus. This situation is similar
to that shown in Fig. 8 (monomer plus three p–S8 peptides). In the present case, when
the p–S8 enters the protein, the RMSD of the associated monomer is increased to a value
≈ 14A˚, which implies that the native conformation is lost.
V. EFFECTS OF MUTATIONS IN HIV–1 PR SEQUENCE
In order to assess the effect mutations of the protease have on the effectiveness of the
p–S8 as inhibitor, we have performed a number of simulations of mutated protease with and
without p–S8. Within the framework of the present model a mutation on a given site is
made operative by switching off all the native interactions made by that site in the wild–
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type sequence, treating them as if they were non–native (cf. Eq. (1)). We have applied this
procedure to a number of sites which are known to be mutated by the virus to escape drugs
(e.g., 19, 37, 63, 67, 72 and 95). Also to sites which belong to LES (31, 33 and 85) or which
interact with a LES (68).
In Fig. 11 we display the population of the native state pN for the mutated monomeric
protease (continuous curve) and for the system composed of the mutated protease and three
p–S8 (dotted curve). All mutations except those on sites 85 and 33 have little effect on
the stability of the protein. On the other hand, the denaturing effect of the p–S8 is fully
retained, as expected from the fact that the interaction between p–S8 and the monomer is
unchanged. In fact, the interaction between p–S8 and the monomer are the same as those
which stabilize the monomer itself. Consequently, the mantained stability of the mutated
protein is a proof of the mantained affinity between p–S8 and the mutated protein.
The mutation on site 33 causes a consistent destabilization of the protease, due to the fact
that it is a hot site belonging to a LES (S2), site where a large fraction of the stabilization
energy of the protein is concentrated. In this case the affinity of the p–S8 to the protease is
also diminished and consequently its destabilizing effect is greatly reduced. In any case the
net effect of this mutation is that the protein becomes quite unstable.
VI. CONCLUSIONS
We have identified fragments 24–34, 83–93 and 75–78 as the local elementary structures
which guide the folding and are responsible for the stability of HIV–1–PR. Peptides with
the same sequence of the fragment 83–93 have shown good inhibitory properties, causing
a consistent unfolding of its native state. It is not likely that HIV–1–PR can develop
resistance against these peptides. To do so, the protease should mutate amino acids which
play an important role in its folding. The strategy presented in this paper seems to solve
the two major problems encountered in drug desing: optimization and resistance. Due to
the universality of the approach, it is suggested that this kind of folding–inhibitor drugs can
be designed and used in connection with other target proteins.
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APPENDIX A: NATURE OF THE HIV–PR DIMER
At low pH, calorimetry experiments have shown [36] that there is a single transition at
T = 59 C (pH 3.4, 25 µM protein, 100 mM NaCl) between the dimeric native state and a
monomeric unfolded state. This means that, for example, at T=25 C there is essentially not
monomeric protease in solution. At this temperature, the stabilization energy of the dimer
is about 10 kcal/mol, but each pair of isolated monomers is unstable (the stabilization free
energy being ≈ −13 kcal/mol), the stabilization energy coming from the interface (≈ +20
kcal/mol).
The analysis of the distribution of stabilization energy among the residues at the interface
indicate that this is concentrated in few ”hot” spots, namely 1, 3, 5 and 95–99. This
behaviour is somewhat odd for a two–state dimer, where typically the stabilization energy is
spread out uniformly on the interface [6]. Note, however, that most likely the evolution of the
HIV protease has mostly taken place in the cytoplasm, which is neutral, and consequently
one should compare its evolutionary properties with its stability features at higher pH.
Increasing the value of pH, acid residues acquire a negative charge. In particular, the
pair of D25 which lie close on the interface repell each other through Coulomb force. The
overall effect is to increase the dissociation constant (measured by sedimentation equilibrium
experiments) which assumes the value kD = 5.8µM at pH 7 (and T = 4C [2], further
increasing at higher temperatures). The dissociation of dimer is accompanied with a decrease
in the internal structure of the monomers, as testified by the fact that CD experiments
highlight a decrease of about 26% of the beta–structure of the protein [2]. Consequently,
one expects a detectable ratio of folded monomers in solution. For instance, according to
a picture where a loss of 26% structure means that 26% of monomers have no structure
at all, the ratio of folded monomers is 18 % (of course, this is an idealized situation. In a
more realistic scenario, a larger ratio of monomers are partially destabilized, e.g. 52% of
monomers loose half of the structure).
One should anyway note that sedimentation equilibrium results are apparently contrad-
dicted by fluorescence essays. The intensity of fluorescence at equilibrium at different values
of pH displays maximum values in the region between pH 4.5 and pH 8, decreasing both
at acidic and basic values of pH [37, 38]. Moreover, equilibrium experiments where the
fluorescence is recorded upon addition of urea at constant pH and the concentration of urea
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corresponding to the midpoint in the change in fluorescence [36] show that the midpoint
concentration of urea increases if pH is increased from 4 to 5.5. These results seem to con-
traddict the results discussed above, suggesting that the protease is more stable at neutral
pH. They also seem to contraddict kinetic fluorescence measurements, where the kinetics
of fluorescence emission upon addition of urea is recorded at different pH. The ”unfolding
rates” thus obtained behave in a specular way as compared to equilibrium measurement,
displaying low rates (i.e., ”more stable”) between pH 4 and 7, and increasing (i.e., ”less
stable”) at the extremes [37].
A summary of the dissociation constants obtained with different tecniques and under
different conditions is presented in Table V. In considering these results, one should re-
member that each monomer of the protease has two TRP residues, at position 6 at the
interface and at position 42 on the surface, at the rear part of the flap. Consequently, not
only fluorescence intensity is not able to distinguish between unfolding of the monomer and
dissociation of the dimer, but more subtle processes such as opening and closing of the flaps
can affect the recorded signal. As a consequence, we consider more reliable the results ob-
tained in sedimentation equilibrium experiments, which is the only direct inspection of the
monomer/dimer character of the solution.
APPENDIX B: DYNAMIC SIMULATIONS
Metropolis Monte Carlo simulations are meant to sample the conformational space of a
system in order to investigate thermodynamical quantities at equilibrium. Nonetheless, it
has been shown that, if the elementary movement of the chain is small enough, the algorithm
describes in an approximated way the dynamics of the system [34], solving effectvely the
Langevin equations associated to the system [35]. In order to transform MC steps into
seconds, we have calculated the diffusion coefficient of the centre of mass of the protein
monomer, and compared it with the one obtained by Stokes’ approximation, describing
diffusion of a spherical object of radius 30A˚ in water at room temperature. The resulting
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relation is 1 MC step equal to 10−13s.
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contact Bij p∞ τ
25-28 -5.4 0.77 2 · 10−10
87-90 -9.8 0.99 4 · 10−10
31-89 -6.1 0.92 2.6 · 10−7
23-85 -4.9 0.86 3.6 · 10−7
62-74 -2.4 0.51 1.0 · 10−6
12-66 -1.5 0.51 1.2 · 10−6
TABLE I: The dynamics of some native contacts of the protein. Bij is the interaction energy
expressed in kJ/mol, p∞ is the asymptotic stability and τ is the average formation time of the
contact in seconds.
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wt mut PAM wt mut PAM wt mut PAM wt mut PAM
P1 T26 G51 L76 V 2
Q2 G27 G52 V77 I 4
I3 V 4 A28 F53 L 2 G78
T4 D29 I54 VMLT 0 P79 A 1
L5 D30 N 2 K55 RH 0 T80
W6 T31 V56 P81 T 0
Q7 V32 I 4 R57 K 3 V82 TAFIS -1
R8 KQL 1 L33 FVI 2 Q58 E 2 N83
P9 E34 DQANG 0 Y59 I84 V 4
L10 FIRV -3 E35 DG 0 D60 E 3 I85 V 4
V11 IL 2 M36 ILV 2 Q61 ENH 1 G86
T12 SPAEIKN 0 S37 DSTEKHC -4 I62 V 4 R87 K
I13 V 4 L38 F 2 L63 PSTACQH -6 N88 DS 1
K14 R 3 P39 SQT 0 I64 VLM 2 L89 MVI 2
I15 V 4 G40 E65 D 3 L90 M 4
G16 EA 0 R41 KN 0 I66 FV 1 T91
G17 E 0 W42 C67 FS -4 Q92 KR 1
Q18 H 3 K43 RT 0 G68 I93 L 2
L19 ITVQP -3 P44 H69 KQYRN 0 G94
K20 MRTIV -2 K45 IRN -2 K70 RTE 0 bf A95 SF -3
E21 M46 FILV 0 A71 TVI -1 T96
A22 I47 V 4 I72 VTLMER -2 L97 V 2
L23 I 2 bf G48 V -1 G73 STCA 1 N98
L24 IVF 2 G49 T74 SAP 0 F99
D25 I50 VL 2 V75 I 4
TABLE II: The observed mutations in proteases reported in ref. [27]. For each residue of the
wild–type sequence (wt) are listed the mutations observed in treated or untreated patients (mut)
and the lowest PAM250 score (see text) among the mutations. In bold the sites which undergo
non–conservative (i.e., non–positive) mutations.
S1+S6 S2+S7+S8 S3+S4+S5
S1+S6 -67.2 -72.6 -19.2
S2+S7+S8 -72.6 -223.6 -117.2
S3+S4+S5 -19.2 -117.2 -144.1
TABLE III: The all atom molecular dynamics energy map of the eight amino acid chain segments
expressed in terms of the folding nucleus (FN: S2+S7+S8), the flap region (S3+S4+S5) and of
S1+S6.
22
np N2(%) 2N(%) U(%) U2(%)
0 30.4 ± 29.1 68.4 ± 29.0 1.1± 0.1 0.1± 0.1
3 0.05 ± 0.05 31.3 ± 16.2 68.6 ± 21.1 0.05± 0.05
TABLE IV: The equilibrium population pN (qE > 0.7, RMSD < 10A˚) of the different states of
the HIV–1–PR dimer in the presence of np p–S8 peptides at T = 2.5kJ/mol: N2) native dimeric
state, 2N) monomers in the native state but not dimerized, U) monomers unfolded and separated,
U2) monomers unfolded but native interactions at the dimer interface formed.
pH T [C] NaCl kD method reference
3.4 25 100 mM 17 nM fluorescence [36]
4.5 4 0 <100 nM sedim. eq. [2]
4.5 9 0 28 µM sedim. eq. (HIV–2) [39]
5 4 0.2 M <10 nM sedim. eq. [38]
5 25 100 mM 23 pM fluorescence [36]
5 37 1 M 3.6 nM activity [40]
7 4 0 5.8 µM sedim. eq. [2]
7 25 1 M 50 nM activity [41]
7.5 9 0 87 µM sedim. eq. (HIV–2) [39]
TABLE V: The values of dissociation constant kD if the dimer, calculated at different conditions.
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FIG. 1: The native homodimer of HIV–1 PR. In the right monomer we have highlighted the local
elementary structures, corresponding to fragments 24–34 and 83–93 (see text).
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FIG. 2: (a) The specific heat of the dimer (solid curve, the values obtained from the simulations
have been divided by 2 in order to obtained the specific heat per monome) and of the monomer
(dashed curve); (b) the order parameter qE associated with the contacts within monomers (dashed
black curve), across the dimer (dashed gray curve) and within the nucleus (contacts between
fragment 22–32 and 83–93) of the monomer (dot–dashed black curve); (c) the RMSD associated
with the whole dimer (solid curve) and with the monomer alone (dashed curve).
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FIG. 3: Dynamic evolution of the monomer. The formation probability [qE](t) of the native
conformation (solid curve) at T = 2.5 kJ/mol, the probability p87−90(t) (dashed gray curve) and
the probability p31−89(t) (dotted gray curve).
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FIG. 4: The contact map of HIV–1–PR, where different gray levels correspond to different values
of the average stabilization time. Darker and lighter symbols correspond to times of the order of
10−10s and 10−7s, respectively.
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FIG. 5: The entropy per site (see text) of proteins structurally similar to the HIV–1–PR monomer
(pdb code: 1BVG). The solid line indicates the entropy function calculated over 28 proteins dis-
playing sequence similarity lower than 25% with the HIV–1–PR, while the dashed line is associated
with 462 proteins irrespectively of sequence similarity.
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FIG. 6: The components of the eigenvector associated with the lowest eigenvalue of the interaction
matrix Bij.
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FIG. 7: The equilibrium probability of the HIV–1 PR monomer as a function of the energetic
parameter qE and of the RMSD for the monomer alone (a), the system composed of the monomer
and 3 peptides p–S8 (b) and of the monomer and 3 peptides corresponding to the sequence 5–15
control peptide (c). The dashed curve indicates the native state.
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FIG. 8: A snapshot of an unfolded conformation taken from the simulation of Fig. 7, where the
peptides p–S8 prevent the folding nucleus of the monomer to get formed.
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FIG. 9: The equilibrium population (pN (≡ p(qE > 0.7, RMDS < 10A˚)), see text Sect. IV) of the
native state of the monomer as a function of the number of peptides p–S8 (T = 2.5 kJ/mol).
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FIG. 10: A snapshot of the simulation of the dimer with 3 p–LES, starting from the native
conformation. The LES of the protein are indicated with a thicker grey tube, while the p–LES are
highlighted in black.
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FIG. 11: The effect of mutations on a number of sites of the monomer (x–axis) on the stability
pN of the native state (y–axis). The solid curve indicate the stability of the monomer alone
(T = 2.5kJ/mol), while the dotted curve refers to the case of the monomer plus 3 p–S8 peptides.
The point drawn at abscissa zero indicates the wild type sequence.
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